Ellen M Ginzler Selected Research

Protein C

2/2010

Endothelial function and its implications for cardiovascular and renal disease in systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ellen M Ginzler Research Topics

Disease

31	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 07/2002
13	Lupus Nephritis 11/2022 - 12/2004
5	Infections 01/2021 - 02/2012
3	Neoplasms (Cancer) 12/2021 - 10/2012
3	Proteinuria 01/2016 - 01/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2013 - 12/2004
2	Headache (Headaches) 12/2021 - 11/2013
2	Rheumatoid Arthritis 12/2021 - 01/2019
2	Pneumonia (Pneumonitis) 01/2021 - 02/2012
2	Body Weight (Weight, Body) 01/2021 - 11/2011
2	Hypertension (High Blood Pressure) 01/2019 - 09/2015
2	Nephritis 01/2016 - 02/2010
1	Cardiotoxicity 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Cutaneous Lupus Erythematosus 12/2021
1	Skin Neoplasms (Skin Cancer) 12/2021
1	Toxic Optic Neuropathy 01/2021
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Multiple Sclerosis 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Cognitive Dysfunction 01/2019
1	Pre-Eclampsia (Preeclampsia) 01/2019
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 10/2018
1	Transient Ischemic Attack 10/2018
1	Stroke (Strokes) 10/2018
1	Mood Disorders (Mood Disorder) 07/2015
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2014
1	Lymphoma (Lymphomas) 01/2014
1	Atherosclerosis 02/2010
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2010
1	Mixed Connective Tissue Disease (MCTD) 08/2007
1	Inflammation (Inflammations) 12/2004
1	Hirsutism 09/2004
1	Stomatitis 09/2004
1	Clinical Deterioration 09/2004
1	Acne Vulgaris 09/2004

Drug/Important Bio-Agent (IBA)

10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 09/2004
10	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016 - 11/2005
9	belimumabIBA 11/2022 - 01/2008
7	AutoantibodiesIBA 01/2019 - 11/2012
6	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 07/2002
5	GlucocorticoidsIBA 12/2021 - 04/2005
4	B-Cell Activating FactorIBA 11/2022 - 01/2008
4	Antimalarials (Antimalarial Agents)IBA 12/2021 - 11/2013
4	Estrogens (Estrogen)FDA Link 11/2012 - 09/2009
4	Dehydroepiandrosterone (DHEA)IBA 08/2008 - 07/2002
3	Monoclonal AntibodiesIBA 11/2022 - 01/2008
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2021
3	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 10/2005
3	SteroidsIBA 09/2015 - 07/2002
3	Azathioprine (Imuran)FDA LinkGeneric 01/2014 - 07/2008
3	CreatinineIBA 11/2011 - 12/2004
2	Antinuclear AntibodiesIBA 01/2022 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2019 - 02/2012
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2018 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2013 - 09/2004
2	Biomarkers (Surrogate Marker)IBA 02/2010 - 09/2009
2	Prednisone (Sone)FDA LinkGeneric 01/2010 - 07/2002
2	Proteins (Proteins, Gene)FDA Link 01/2010 - 12/2004
2	Biological ProductsIBA 09/2009 - 01/2008
1	Chloroquine (Aralen)FDA LinkGeneric 12/2021
1	Calcineurin InhibitorsIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	voclosporinIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Cytidine Monophosphate (CMP)IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	BC1 RNAIBA 01/2019
1	Contraceptive Agents (Contraceptives)IBA 01/2019
1	AMG623 peptibodyIBA 08/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2014
1	Immunologic Factors (Immunomodulators)IBA 01/2014
1	TACI receptor-IgG Fc fragment fusion proteinIBA 02/2012
1	AdiponectinIBA 02/2010
1	Protein CIBA 02/2010
1	Endothelial Protein C ReceptorIBA 02/2010
1	Gm(m)IBA 01/2010
1	Complement Factor B (Factor B)IBA 01/2008
1	Waste Products (Waste Product)IBA 12/2004
1	AntibodiesIBA 12/2004

Therapy/Procedure

22	Therapeutics 11/2022 - 09/2004
1	Contraindications 01/2019
1	Time-to-Treatment 11/2011
1	Remission Induction 07/2008